Maxcyte annual total assets
2020
2021
2022
2023
2024
2025
Maxcyte Total Assets Growth & History (MXCT)
Maxcyte's total assets was $202.5M for fiscal 2025.
View full Maxcyte company overviewMaxcyte annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $202.5M | −$37.0M | −15.44% |
| 2024 | 2024-12-31 | $239.5M | −$28.8M | −10.74% |
| 2023 | 2023-12-31 | $268.3M | −$18.4M | −6.41% |
| 2022 | 2022-12-31 | $286.7M | $2.5M | +0.89% |
| 2021 | 2021-12-31 | $284.1M | $232.3M | +448.71% |
| 2020 | 2020-12-31 | $51.8M | — | — |
Maxcyte quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $184.7M | −$35.1M | −15.96% |
| Q1 2026 | 2026-03-31 | $194.5M | −$35.5M | −15.43% |
| Q4 2025 | 2025-12-31 | $202.5M | −$37.0M | −15.44% |
| Q3 2025 | 2025-09-30 | $213.5M | −$35.1M | −14.13% |
| Q2 2025 | 2025-06-30 | $219.8M | −$31.7M | −12.62% |
| Q1 2025 | 2025-03-31 | $230.0M | −$28.0M | −10.84% |
| Q4 2024 | 2024-12-31 | $239.5M | −$28.8M | −10.74% |
| Q3 2024 | 2024-09-30 | $248.6M | −$18.1M | −6.79% |
| Q2 2024 | 2024-06-30 | $251.5M | −$19.7M | −7.27% |
| Q1 2024 | 2024-03-31 | $257.9M | −$23.6M | −8.39% |
| Q4 2023 | 2023-12-31 | $268.3M | −$18.4M | −6.41% |
| Q3 2023 | 2023-09-30 | $266.7M | −$19.7M | −6.87% |
| Q2 2023 | 2023-06-30 | $271.2M | −$18.6M | −6.41% |
| Q1 2023 | 2023-03-31 | $281.5M | −$9.4M | −3.23% |
| Q4 2022 | 2022-12-31 | $286.7M | $2.5M | +0.89% |
| Q3 2022 | 2022-09-30 | $286.4M | $8.7M | +3.14% |
| Q2 2022 | 2022-06-30 | $289.8M | $196.6M | +211.10% |
| Q1 2022 | 2022-03-31 | $291.0M | — | — |
| Q4 2021 | 2021-12-31 | $284.1M | $232.3M | +448.71% |
| Q3 2021 | 2021-09-30 | $277.7M | — | — |
| Q2 2021 | 2021-06-30 | $93.1M | — | — |
| Q4 2020 | 2020-12-31 | $51.8M | — | — |
Maxcyte total assets trends
Over the last five fiscal years, Maxcyte's total assets increased from $51.8M to $202.5M, a change of $150.7M. The latest reported quarter, Q2 2026, shows $184.7M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maxcyte source filings ↗